SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-005833
Filing Date
2021-01-20
Accepted
2021-01-20 16:16:17
Documents
1
Period of Report
2021-01-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211939-2_4.html 4  
1 OWNERSHIP DOCUMENT tm211939-2_4.xml 4 8191
  Complete submission text file 0001104659-21-005833.txt   9598
Mailing Address C/O NXSTAGE MEDICAL INC. (NXTM) 439 SOUTH UNION STREET, 5TH FLOOR LAWRENCE MA 01843
Business Address
GILL DAVID N (Reporting) CIK: 0001106519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 21538947

Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations